KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Current Leases (2019 - 2025)

Historic Current Leases for ClearPoint Neuro (CLPT) over the last 7 years, with Q3 2025 value amounting to $347000.0.

  • ClearPoint Neuro's Current Leases fell 3526.12% to $347000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $347000.0, marking a year-over-year decrease of 3526.12%. This contributed to the annual value of $557000.0 for FY2024, which is 3136.79% up from last year.
  • According to the latest figures from Q3 2025, ClearPoint Neuro's Current Leases is $347000.0, which was down 3526.12% from $331000.0 recorded in Q2 2025.
  • ClearPoint Neuro's 5-year Current Leases high stood at $578000.0 for Q1 2025, and its period low was $331000.0 during Q2 2025.
  • In the last 5 years, ClearPoint Neuro's Current Leases had a median value of $511500.0 in 2021 and averaged $488000.0.
  • As far as peak fluctuations go, ClearPoint Neuro's Current Leases soared by 31653.89% in 2021, and later plummeted by 3585.27% in 2025.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Current Leases stood at $507000.0 in 2021, then rose by 10.65% to $561000.0 in 2022, then fell by 24.42% to $424000.0 in 2023, then soared by 31.37% to $557000.0 in 2024, then crashed by 37.7% to $347000.0 in 2025.
  • Its Current Leases stands at $347000.0 for Q3 2025, versus $331000.0 for Q2 2025 and $578000.0 for Q1 2025.